Email UpdatesLiterature Collection
Collection Insights
11K+
References
9K+
Articles
1400+
Grey Literature
4600+
Opioids & SU
The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More
Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).
11199 Results
3601
Enhancing the Role of the Nurse in Primary Care: The RN "Co-Visit" Model
Type: Journal Article
Year: 2015
Topic(s):
Education & Workforce
See topic collection
Reference Links: 
View the DOI record for Enhancing the Role of the Nurse in Primary Care: The RN "Co-Visit" Model
View DOI Record
View the PubMed citation for Enhancing the Role of the Nurse in Primary Care: The RN "Co-Visit" Model3602
Enhancing the scalability of the collaborative care model for depression using mobile technology
Type: Journal Article
Year: 2020
Publication Place: England
Topic(s):
Education & Workforce
See topic collection
, Healthcare Disparities
See topic collection
, HIT & Telehealth
See topic collection
Reference Links:
View the DOI record for Enhancing the scalability of the collaborative care model for depression using mobile technology
View DOI Record
View the PubMed citation for Enhancing the scalability of the collaborative care model for depression using mobile technology3603
Ensuring buprenorphine access in rural community pharmacies to prevent overdoses
Type: Journal Article
Year: 2022
Publication Place: United States
Topic(s):
Education & Workforce
See topic collection
, Healthcare Disparities
See topic collection
, Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Ensuring buprenorphine access in rural community pharmacies to prevent overdoses
View DOI Record
View the PubMed citation for Ensuring buprenorphine access in rural community pharmacies to prevent overdoses3604
Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems
Type: Journal Article
Year: 2012
Publication Place: England
Abstract: BACKGROUND: Buprenorphine is an effective treatment for opioid dependence that can be provided in a primary care setting. Offering this treatment may also facilitate the identification and treatment of other chronic medical conditions. METHODS: We retrospectively reviewed the medical records of 168 patients who presented to a primary care clinic for treatment of opioid dependence and who received a prescription for sublingual buprenorphine within a month of their initial visit. RESULTS: Of the 168 new patients, 122 (73%) did not report having an established primary care provider at the time of the initial visit. One hundred and twenty-five patients (74%) reported at least one established chronic condition at the initial visit. Of the 215 established diagnoses documented on the initial visit, 146 (68%) were not being actively treated; treatment was initiated for 70 (48%) of these within one year. At least one new chronic medical condition was identified in 47 patients (28%) during the first four months of their care. Treatment was initiated for 39 of the 54 new diagnoses (72%) within the first year. CONCLUSIONS: Offering treatment for opioid dependence with buprenorphine in a primary care practice is associated with the identification and treatment of other chronic medical conditions.
Topic(s):
Healthcare Disparities
See topic collection
, Opioids & Substance Use
See topic collection
3605
Enzymatic assays for detecting lactose and sucrose in urine to reveal intravenous drug abuse with emphasis on buprenorphine
Type: Journal Article
Year: 2017
Publication Place: England
Topic(s):
Opioids & Substance Use
See topic collection
3606
Epidemiologic trends and costs of fragmentation
Type: Journal Article
Year: 2006
Topic(s):
Financing & Sustainability
See topic collection
3607
Epidemiology of depression in primary care
Type: Journal Article
Year: 1992
Publication Place: UNITED STATES
Abstract: Major depressive disorder has been recently found to be associated with high medical utilization and more functional impairment than most chronic medical illnesses. Major depression is a common illness among persons in the community, in ambulatory medical clinics, and in inpatient medical care. Studies have estimated that major depression occurs in 2%-4% of persons in the community, in 5%-10% of primary care patients, and 10%-14% of medical inpatients. In each setting there are two to three times as many persons with depressive symptoms that fall short of major depression criteria. Recent studies have found that in one-third to one-half of patients with major depression, the symptoms persist over a 6-month to one-year period. The majority of longitudinal studies have determined that severity of initial depressive symptoms and the presence of a comorbid medical illness were predictors of persistence of depression.
Topic(s):
Key & Foundational
See topic collection
3608
Equipping providers with principles, knowledge and skills to successfully integrate behaviour change counselling into practice: a primary healthcare framework
Type: Journal Article
Year: 2018
Publication Place: Netherlands
Topic(s):
Education & Workforce
See topic collection
3609
Equitable access to mental healthcare integrated in primary care for people with severe mental disorders in rural Ethiopia: a community-based cross-sectional study
Type: Journal Article
Year: 2019
Publication Place: England
Topic(s):
Education & Workforce
See topic collection
, Healthcare Disparities
See topic collection
3611
Equity-oriented frameworks to inform responses to opioid overdoses: a scoping review
Type: Journal Article
Year: 2021
Publication Place: United States
Topic(s):
Healthcare Disparities
See topic collection
, Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Equity-oriented frameworks to inform responses to opioid overdoses: a scoping review
View DOI Record
View the PubMed citation for Equity-oriented frameworks to inform responses to opioid overdoses: a scoping review3613
Eradicating the Overuse of Opioids on the Front Line
Type: Journal Article
Year: 2017
Publication Place: United States
Topic(s):
Opioids & Substance Use
See topic collection
3614
Erectile Dysfunction Among Patients on Methadone Maintenance Therapy and Its Association With Quality of Life
Type: Journal Article
Year: 2017
Publication Place: United States
Abstract: OBJECTIVES: Erectile dysfunction (ED) is a problem commonly encountered by patients on methadone maintenance therapy (MMT). This study aimed to assess the prevalence of ED among this group of patients along with its risk factors and association with quality of life (QOL). METHODS: Male patients on MMT in a tertiary hospital in Malaysia were included in the study. A total of 134 patients with sexual partners were assessed for ED using the International Index of Erectile Function. Patients were assessed for substance use using Opiate Treatment Index (OTI) and depression using the Malay version of the self-rated Montgomery-Asberg Depression Rating Scale (MADRS-BM). QOL was evaluated using World Health Organisation Quality of Life (WHOQOL)-BREF. RESULTS: The prevalence of ED among patients on MMT was 67%, with 26.1% having mild ED, 30.4% having mild-to-moderate ED, 7.0% having moderate ED, and 17.2% having severe ED. Patients with depression were 4 times more likely to have ED compared with patients without depression, whereas increasing age significantly correlated with the severity of ED. Having ED predicted a poorer QOL in the social relationships domain. CONCLUSION: Depression is highly associated with ED, which negatively influences the social aspect of QOL among patients on methadone maintenance therapy.
Topic(s):
Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Erectile Dysfunction Among Patients on Methadone Maintenance Therapy and Its Association With Quality of Life
View DOI Record
View the PubMed citation for Erectile Dysfunction Among Patients on Methadone Maintenance Therapy and Its Association With Quality of Life3615
Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study
Type: Journal Article
Year: 2017
Publication Place: United States
Abstract: BACKGROUND: Erectile dysfunction (ED) is common among men on opioid replacement therapy (ORT), but most previous studies exploring its prevalence and determinants yielded contrasting findings. Moreover, the impact of ED on patients' quality of life (QoL) has been seldom explored. OBJECTIVE: To explore the prevalence and determinants of ED in men on ORT, and the impact on QoL. METHODS: In a multicentre cross-sectional study, we recruited 797 consecutive male patients on methadone and buprenorphine treatment, collected data on demographic, clinical, and psychopathological factors, and explored their role as predictors of ED and QoL through univariate and multivariate analysis. ED severity was assessed with a self-assessment questionnaire. RESULTS: Nearly half of patients in our sample were sexually inactive or reported some degree of ED. Some demographic, clinical and psychopathological variables significantly differed according to the presence or absence of ED. Multivariate regression analysis indicated that age, employment, smoke, psychoactive drugs, opioid maintenance dosage, and severity of psychopathological factors significantly influenced the risk and severity of ED. QoL was worse in patients with ED and significantly correlated with ED severity. Age, education, employment, opioid maintenance dosage, ED score, and severity of psychopathology significantly influenced QoL in the multivariate analysis. CONCLUSIONS: ED complaints can be explored in male opioid users on ORT through a simple and quick self-assessment tool. ED may have important effects on emotional and social well-being, and may affect outcome.
Topic(s):
Opioids & Substance Use
See topic collection
3616
Erratum to: The Affordable Care Act and integrated behavioral health programs in community health centers to promote utilization of mental health services among Asian Americans
Type: Journal Article
Year: 2016
Publication Place: United States
Topic(s):
Healthcare Disparities
See topic collection
, Healthcare Policy
See topic collection
3617
Error and bias in the evaluation of prescription opioid misuse: should the FDA regulate clinical assessment tools?
Type: Journal Article
Year: 2013
Publication Place: England
Abstract: BACKGROUND: Clinicians who prescribe chronic opioid therapy are concerned about identifying patients who are at-risk for misusing, abusing, or diverting (i.e. selling) their pain medications. Experts have specifically recommended using clinical assessment tools as part of a comprehensive plan for mitigating opioid-related risks. These tools are typically short, standardized questionnaires that screen for the presence or absence of putatively aberrant medication-related behaviors thought to be predictive of addiction. Interestingly, these tools remain wholly unregulated by the Food and Drug Administration (FDA) or other authorities. OBJECTIVE: This paper reviews how these instruments are used and the normative assumptions informing their use, fully appreciating that these screening tools do not have the power to diagnose illness or an addiction disorder. CONCLUSION: We conclude that these clinical assessment tools should be regulated because, as we will argue, any screening tool that can assess patients for the potential for opioid-related aberrant behaviors are powerful instruments that merit additional scrutiny and oversight--perhaps by the FDA and other regulatory agencies.
Topic(s):
Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Error and bias in the evaluation of prescription opioid misuse: should the FDA regulate clinical assessment tools?
View DOI Record
View the PubMed citation for Error and bias in the evaluation of prescription opioid misuse: should the FDA regulate clinical assessment tools?